A correction to a summary published March 24, 2010
In the summary “Rifaximin for Maintaining Remission in Hepatic Encephalopathy,” published online March 24, 2010, the dosage of rifaximin received by patients should have been listed as 550 mg twice daily, not as 55 mg twice daily. We have corrected the error in our original summary, and we apologize for the error.